2-HG optimized MR spectroscopic imaging showed 2HG was detected in 37 out of 40 IDH1+ patients. Although it was not significantly different between IDH+ and IDH- gliomas, significant correlation was found with progression free survival in newly-diagnosed grade II and grade III gliomas.
This abstract and the presentation materials are available to members only; a login is required.